From Plant Cells to AI-Driven Solutions: Protalix BioTherapeutics’ Journey in Modern Biopharmaceuticals
Protalix BioTherapeutics Inc., an innovative Israeli pharmaceutical company, has garnered attention for its plant-based production of biopharmaceuticals, most notably taliglucerase alfa for Gaucher disease. This paper explores the integration of Artificial Intelligence (AI) into Protalix’s biopharmaceutical manufacturing processes, focusing on enhancing production efficiency, optimizing protein engineering, and improving clinical outcomes. AI-driven methodologies, including machine learning…